MercadoLibre, Inc. to Report First Quarter 2017 Financial Results
Apr 27, 2017 20:02 pm UTC| Business
BUENOS AIRES, Argentina, April 27, 2017 -- MercadoLibre, Inc. (Nasdaq:MELI) (http://www.mercadolibre.com) intends to release financial results for its first fiscal quarter ended March 31, 2017 on May 4th, 2017 after the...
MercadoLibre, Inc. to Report First Quarter 2017 Financial Results
Apr 27, 2017 20:02 pm UTC| Business
BUENOS AIRES, Argentina, April 27, 2017 -- MercadoLibre, Inc. (Nasdaq:MELI) (http://www.mercadolibre.com) intends to release financial results for its first fiscal quarter ended March 31, 2017 on May 4th, 2017 after the...
Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
Apr 27, 2017 20:02 pm UTC| Business
COLORADO SPRINGS, Colo., April 27, 2017 -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today reported financial results for the three months ended March31, 2017. Highlights of the quarter, all compared...
Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
Apr 27, 2017 20:02 pm UTC| Business
COLORADO SPRINGS, Colo., April 27, 2017 -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today reported financial results for the three months ended March31, 2017. Highlights of the quarter, all compared...
athenahealth, Inc. Reports First Quarter Fiscal Year 2017 Results
Apr 27, 2017 20:02 pm UTC| Business
Company Revises Fiscal Year 2017 Financial Outlook Q1 2017 Financial Results 11% Revenue Growth Over First Quarter of 2016GAAP Operating Income of $1.1 million Non-GAAP Adjusted Operating Income of $22.0 millionGAAP...
athenahealth, Inc. Reports First Quarter Fiscal Year 2017 Results
Apr 27, 2017 20:02 pm UTC| Business
Company Revises Fiscal Year 2017 Financial Outlook Q1 2017 Financial Results 11% Revenue Growth Over First Quarter of 2016GAAP Operating Income of $1.1 million Non-GAAP Adjusted Operating Income of $22.0 millionGAAP...
Harvard Bioscience Reports First Quarter 2017 Financial Results
Apr 27, 2017 20:02 pm UTC| Business
HOLLISTON, Mass., April 27, 2017 -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its...